Chapter 191: Patent infringement?

Xiao Ming returned to Prajna.
Before the completion of the industrial park, Panruo Village was the largest base of Pangu technology.
So far, with the exception of the translation dog business department and the system business department in Guangyao Building, the rest of the departments are in Pranjo Village.
Gao Siqi reported the specific situation to Xiao Ming, which sounded more serious than expected.
Even if Pangu Technology succeeded in treating a patient, even if Pangu Technology published a paper, from the perspective of clinical treatment effects, the gene suppression technology is similar to the appearance of nivolumab treatment.
Especially waiting for cancer cells to die, this is the most typical manifestation of PD-1 treatment.
Gao Siqi said: "On the surface, the status and indicators of successful patients are similar, so Bristol-Myers Squibb identified us as embezzling his intellectual property."
Xiao Ming reluctantly said: "From the final indicators, if nivolumab really has a significant effect on patients, then there is really no difference between the two, because everyone's indicators are close to normal, but in essence the two Is absolutely different. "
"What if we don't accept a letter from a lawyer?"
"It will be prosecuted." Gao Siqi said: "Xia Guo has joined 26 international intellectual property rights treaty organizations including the" Convention on the Establishment of the World Intellectual Property Organization. " Strict protection. "
In its implementation, Guibao Company cares not only intellectual property rights, but also the market profit of 100 billion meters of knives.
The treatment cost of nivolumab is 40,000 yuan per month and 480,000 yuan per year.
According to a patient's five-year life expectancy, the patient would spend 2.4 million yuan.
And what about Pangu Technology's treatment technology? About 300,000 people can recover into healthy people.
And the therapeutic effect of targeted drugs still depends on the chance, there is no 100% certainty.
The patient is not a fool and will definitely seek treatment from Pangu Technology.
In the foreseeable future, when suppressive gene therapies have captured more cancers, this market will be left without the survival space of Bristol-Myers Squibb, Bayer and other companies developing targeted therapeutic drugs.
All patients and treatment costs will go to Xia Guo, to medical institutions centered on Pangu Technology.
The transfer of medical centers around the world to Xia Kingdom is the most terrifying and most worrying Western society.
"If the other party sues us, no matter what the final truth is, we will suspend the clinical treatment qualification of using our suppression gene expression technology internationally."
"Internationally?" Xiao Ming asked.
"Yes, internationally. This will affect our vigorous promotion of this technology into the clinic."
Among the 26 related intellectual property rights and patents, the agreement for high-end cutting-edge sciences such as life sciences is that if there is a dispute between the two parties, the relevant patented products of both parties will be stopped at the same time in the member states of intellectual property rights, waiting for Shuangfa to reach an agreement or final Only after the arbitration can Lifan continue to use the patented product.
"Where is it at home?" Xiao Ming is more concerned about domestic issues, after all, technology is still far away from international promotion.
Gao Siqi's words made Xiao Ming feel a bit short-circuited in her brain. She said: "For other countries, Xia Guo is also a member of an international organization, so the ban is effective for Xia Guo."
Xiao Ming: "... really hard."
Gao Siqi has studied this comparison, saying: "Rules are human. Usually the other party does not have clear evidence to prove that we are infringing. We can still use the technology in our country in clinical practice, but we have to fight for it."
Xiao Ming said, "It is indeed a good thing for Pangu Technology. We also have to take this opportunity to prove to the world that Xia Guo medicine has already taken the lead in the world."
Gao Siqi said: "In fact, it still depends on the attitude of Jiangcheng University and related departments."
Gao Siqi analyzed: "Now Xia Guo is in line with international standards in the field of intellectual property, and hopes to establish a global image of protecting intellectual property rights. Xia Guo hopes to throw away the hats of theft and cottage in the world, so that Xia Guo can introduce more and more advanced technology."
Internationally, the accusations made by the rice and EU countries against Xia Guo are the theft of intellectual property rights of other countries.
The country also set a name for the embargo on science and technology in China. The reason for the embargo is that Xia Guo does not respect the intellectual property rights of science and technology, and the embargo on science and technology is exactly the reason why the country has a huge trade deficit with Xia.
Xia Guo now wants to show everyone that he also respects the image of intellectual property. In fact, I don't know that the international community's discrimination against Xia Guo is innate. No matter how hard you try, you can't change the views of China and Europe on you.
Xiao Ming said, "Why do we develop technology without caring about the feelings of the international community? What we care about is the feelings of patients."
"So?" Gao Siqi said, "Ignore it?"
"Of course, don't bother. We don't fight, either Squibb or Mi. If there is any objection to our technology, speak with evidence."
Xiao Ming said with a sneer: "We have no objection to treating patients in the Mi country ~ EbookFREE.me ~ If the Mi people set up obstacles for us, it will only hurt the ordinary people in Mi country.
Gao Siqi said: "Yeah! We develop our technology and treat Xia Guoren. What matters to these Mi Guoren!"
In front of Xiao Ming, Gao Siqi ripped off the other party's lawyer's letter.
Sure enough, two days later, Bristol-Myers Squibb took further steps.
First, they published an article in the New York Times, pointing directly at the plagiarism of Pangu Technology, and gave a lot of examples.
For example, Bristol-Myers Squibb successfully used liver cancer to treat patients with liver cancer five years ago. For example, patients who received liver cancer had color Doppler ultrasound indexes and blood indexes that were similar to those published by Pangu Technology.
At the same time, Bristol-Myers Sue was sued by Pangu Technology in a local court in New York, asking Pang-Gu Technology to immediately ban the use of suppressive gene expression therapy to treat patients, apologize to Bristol-Myers Squibb, and compensate Bristol-Myers Squibb for one billion meters in accordance with the relevant provisions of intellectual property infringement! FDA (Food and Drug Administration) is also required to impose a fine on Pangu Technology!
This is quite excessive, which means that Bristol-Myers Squibb requested that the country use the local laws of the country to adjudicate a Xia country company!
This seemingly arrogant request is actually the consistent approach of the Mi people, replacing the international law with the Mi domestic law, and even the Xia law.
At the beginning, Xia Guo companies such as Warwick and Center all suffered such treatment.
Things really did, as expected by Bristol-Myers Squibb, the FDA of the State of China raised serious concerns with relevant departments of Xia Guo, asking the Affiliated Hospital of Jiangcheng University to stop using gene suppression therapy to treat patients.
At the same time, the New York court formally accepted the case.
https: //
Genius remember the address of this site in a second :. Mobile website reading URL: